Home › Oligodendroglioma › Massachusetts › Boston
Oligodendroglioma clinical trials in Boston, MA
4 studies for Oligodendroglioma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
RecruitingPhase 2
- Massachusetts General Hospital, Boston
Implantable Microdevice In Primary Brain Tumors
RecruitingEarly phase 1
- Brigham and Women's Hospital, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Susan Chi, Boston
Oligodendroglioma trials in other cities
- Houston, TX4 studies
- Miami, FL4 studies
- Philadelphia, PA3 studies
- Aurora, CO3 studies
- Cleveland, OH3 studies
- St. Louis, MO3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.